|
See related Engerix-B information |
|
|
|
Manufacturer |
GlaxoSmithKline |
|
Distributor |
Zuellig |
|
Contents |
HBsAg vaccine, adsorbed |
|
Indications |
Active immunisation against HBV infection.
Click to view Engerix-B detailed prescribing infomation |
|
Dosage |
20 mcg/mL Adult ≥20 yr 1 mL IM. 10 mcg/0.5 mL Neonate, infant & childn up to & including 19 yr 0.5 mL IM inj. All doses to be given at 0, 1, 6 mth; or 0, 1, 2 + booster at 12 mth; or 0, 7, 21 days + booster at 12 mth (for subjects ≥20 yr only).
Click to view Engerix-B detailed prescribing infomation |
|
Overdosage |
View Engerix-B overdosage for action to be taken in the event of an overdose. |
|
Contraindications |
Hypersensitivity.
Click to view Engerix-B detailed prescribing infomation |
|
Special Precautions |
Do not administer in the buttock, intradermally or intravascularly. Postpone administration in acute febrile illness. Renal insufficiency, haemodialysis, HIV-infected or immunocompromised patients. Risk of apnoea & resp monitoring for 48-72 hr in very premature infants (≤28 wk of gestation). Pregnancy, subjects >40 yr.
Click to view Engerix-B detailed prescribing infomation |
|
Adverse Drug Reactions |
Irritability, inj site reactions, fatigue, appetite loss, headache, drowsiness, GI symptoms, fever ≥37.5°C.
View ADR Monitoring Form |
|
Drug Interactions |
[Click for Engerix-B detailed prescribing infomation]
View more drug interactions with Engerix-B |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Caution For Usage |
For caution against possible variation of physical aspect of medicine... click to view Engerix-B detailed prescribing infomation |
|
Storage |
View Engerix-B storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Engerix-B description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Engerix-B mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Engerix-B adult vaccine (inj) |
|
Engerix-B 20 mcg/1 mL x 1 mL x 1's |
|
|
Engerix-B pediatric vaccine (inj) |
|
Engerix-B 10 mcg/0.5 mL x 0.5 mL x 1's |
|
|
|
Manufacturer: |
GlaxoSmithKline |
|
Distributor: |
Zuellig |
|
|
|
